Analgesic composition and method of relieving pain

Claim 2

An analgesic composition comprising an aqueous solution of a parasympathomimetic agent adapted for topical application to the genitalia of a human or nonhuman animal wherein the concentration of said neurologically active agent in said solution is from about 10 -3 to about 10 -13 grams/ml.

Claim 3

An analgesic composition according to claim 1 wherein said parasympathomimetic agent is nicotine or muscarine.

Claim 4

An analgesia composition in kit form comprising (1) an aqueous solution of a parasympathomimetic agent adapted for application to the genitalia of a human or non-human animal wherein the concentration of said neurologically active agent is from about 10 -3 to about 10 -13 grams/ml and (2)(a) a neurologically nutritive amount of at least one nutrient for the nervous system; (b) an agent selected from the group consisting of caffeine, diazepam, tobacco adapted for burning and inhalation of the smoke thereof, or a composition adapted for the production of a nicotine containing vapor or spray capable of inhalation, or (c) mixtures thereof, said nutrient and/or agent being adapted for parenteral administration to said human or non-human animal.

Claim 5

An analgesia composition in kit form comprising (1) an aqueous solution of a parasympathomimetic agent adapted for application to the genitalia of a human or non-human animal wherein the concentration of said neurologically active agent is from about 10 -3 to about 10 -13 grams/ml and (2)(a) a neurologically nutritive amount of at least one nutrient for the nervous system; (b) an agent selected from the group consisting of caffeine, diazepam, tobacco adapted for burning and inhalation of the smoke thereof, or a composition adapted for the production of a nicotine containing vapor or spray capable of inhalation, or (c) mixtures thereof, said nutrient and/or agent being adapted for parenteral administration to said human or non-human animal.

Claim 6

A composition in kit form according to claim 3 wherein said neurologically active agent is nicotine, arecoline, pilocarpine, muscarine, methacholine, oxotremorine, xylocaine or pharmaceutically acceptable derivatives thereof.

Claim 7

A composition in kit form according to claim 3 wherein said nutrient is potassium, manganese, vitamin E, vitamin K, L-α-phosphatidylcholine, choline, pantothenic acid, GABA, L-tryptopham, PABA, or pharmaceutically acceptable derivatives thereof or a mixture thereof.

Claim 10

A method of analgesia according to claim 5 wherein said parasympathomimetic agent is nicotine or muscarine.

Claim 11

A method of analgesia according to claim 6 wherein said aqueous solution of parasympathomimetic agent is administered in conjunction with administration to the human or non-human animal of a neurologically nutritive amount of at least one nutrient for the nervous system.

Claim 12

A method of analgesia according to claim 7 wherein said nutrient is potassium, manganese, vitamin E, vitamin K, L-α-phosphatidylcholine, choline, pantothenic acid, GABA, L-tryptophan, PABA, pharmaceutically acceptable derivatives thereof or a mixture thereof.

Claim 13

A method of analgesia according to claim 6 or 8 wherein the aqueous solution of parasympathomimetic agent is administered to said human or non-human animal in conjunction with parenteral administration thereto of caffeine or diazepam or the inhalation of nicotine containing vapor or spray.